药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tolazamide
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Saquinavir.
Tolazamide
Levocetirizine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Saquinavir.
Tolazamide
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Saquinavir.
Tolazamide
Sevoflurane
The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Saquinavir.
Tolazamide
Perhexiline
The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Saquinavir.
Tolazamide
Salbutamol
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Saquinavir.
Tolazamide
Alimemazine
The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Saquinavir.
Tolazamide
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Saquinavir.
Tolazamide
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Saquinavir.
Tolazamide
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Saquinavir.
Tolazamide
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Saquinavir.
Tolazamide
Lorajmine
The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Saquinavir.
Tolazamide
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Saquinavir.
Tolazamide
Prajmaline
The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Saquinavir.
Tolazamide
Cibenzoline
The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Saquinavir.
Tolazamide
Cicletanine
The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Saquinavir.
Tolazamide
Pilsicainide
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Saquinavir.
Tolazamide
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Saquinavir.
Tolazamide
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Saquinavir.
Tolazamide
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Saquinavir.